ACADIA Pharmaceuticals Funding & Investors
Pharmaceutical company, which developed Nuplazid, based in San Diego, California.
acadia-pharm.comTotal Amount Raised: $811,734,976
ACADIA Pharmaceuticals Funding Rounds
Post Ipo Equity
$287,500,000
Post Ipo Equity
$316,249,997
Post Ipo Equity
$86,385,000
Grant
$2,400,000
Grant Investors
National Institute of Neurological Disorders and Stroke (NINDS)Post Ipo Equity
$15,000,000
Post Ipo Equity Investors
VenrockNEA - New Enterprise AssociatesPost Ipo Equity
$20,000,000
Post Ipo Equity Investors
Nomura InternationalOxford Bioscience PartnersPost Ipo Equity
$10,000,000
Post Ipo Equity Investors
Oxford Bioscience PartnersSeries F
$25,000,000
Series F Investors
Oxford Bioscience PartnersOrbiMed AdvisorsLD PensionsTekla Capital ManagementABN AMRO FundFederated HermesForbion Capital PartnersDebt Financing
$22,000,000
Debt Financing Investors
Tekla World Healthcare FundThe Kaufman FundDKA CapitalPacific Rim VenturesOrbiMed AdvisorsSeries D
$10,700,000
Series D Investors
LD PensionsDKA CapitalSeries B
$3,000,000
Series B Investors
BankInvestLD PensionsDKA CapitalDebt Financing
$7,500,000
Debt Financing Investors
VækstfondenSeries A
$6,000,000
Series A Investors
BankInvestLD PensionsDKA CapitalIPO
Unknown
Funding info provided by Diffbot.